Su W[au] - Search Results

Year	Number of Results
1970	1
1973	4
1974	2
1976	3
1977	2
1978	2
1979	4
1980	6
1981	3
1982	5
1983	13
1984	16
1985	22
1986	11
1987	19
1988	21
1989	20
1990	28
1991	27
1992	40
1993	28
1994	25
1995	38
1996	32
1997	34
1998	29
1999	25
2000	37
2001	52
2002	70
2003	59
2004	56
2005	72
2006	110
2007	90
2008	118
2009	113
2010	165
2011	208
2012	266
2013	209
2014	232
2015	277
2016	256
2017	342
2018	439
2019	470
2020	580
2021	657
2022	743
2023	6

1

XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury.

Liu Z, Wang M, Wang X, Bu Q, Wang Q, Su W, Li L, Zhou H, Lu L. Liu Z, et al. Among authors: su w. Redox Biol. 2022 Jun;52:102305. doi: 10.1016/j.redox.2022.102305. Epub 2022 Mar 28. Redox Biol. 2022. PMID: 35367811 Free PMC article.

2

Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.

Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, Zhou S, Su W, Liu M, Liu Z, Wang M, Lu L. Wang Q, et al. Among authors: su w. J Hepatol. 2022 Aug;77(2):312-325. doi: 10.1016/j.jhep.2022.02.031. Epub 2022 Mar 12. J Hepatol. 2022. PMID: 35292349 Free article.

3

Lipid metabolism in T cell signaling and function.

Lim SA, Su W, Chapman NM, Chi H. Lim SA, et al. Among authors: su w. Nat Chem Biol. 2022 May;18(5):470-481. doi: 10.1038/s41589-022-01017-3. Epub 2022 Apr 28. Nat Chem Biol. 2022. PMID: 35484263 Review.

4

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Gärtner J, Hauser SL, Bar-Or A, Montalban X, Cohen JA, Cross AH, Deiva K, Ganjgahi H, Häring DA, Li B, Pingili R, Ramanathan K, Su W, Willi R, Kieseier B, Kappos L. Gärtner J, et al. Among authors: su w. Mult Scler. 2022 Sep;28(10):1562-1575. doi: 10.1177/13524585221078825. Epub 2022 Mar 10. Mult Scler. 2022. PMID: 35266417 Free PMC article. Clinical Trial.

5

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.

Su W, Mukherjee R, Yaeger R, Son J, Xu J, Na N, Merna Timaul N, Hechtman J, Paroder V, Lin M, Mattar M, Qiu J, Chang Q, Zhao H, Zhang J, Little M, Adachi Y, Han SW, Taylor BS, Ebi H, Abdel-Wahab O, de Stanchina E, Rudin CM, Jänne PA, McCormick F, Yao Z, Rosen N. Su W, et al. Mol Cell. 2022 Jul 7;82(13):2443-2457.e7. doi: 10.1016/j.molcel.2022.04.034. Epub 2022 May 24. Mol Cell. 2022. PMID: 35613620 Free article.

6

The association between pregnancy and COVID-19: A systematic review and meta-analysis.

Wang H, Li N, Sun C, Guo X, Su W, Song Q, Liang Q, Liang M, Ding X, Lowe S, Bentley R, Sun Y. Wang H, et al. Among authors: su w. Am J Emerg Med. 2022 Jun;56:188-195. doi: 10.1016/j.ajem.2022.03.060. Epub 2022 Apr 6. Am J Emerg Med. 2022. PMID: 35413655 Free PMC article. Review.

7

Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.

Su W, Patrício MI, Duffy MR, Krakowiak JM, Seymour LW, Cawood R. Su W, et al. Nat Commun. 2022 Mar 7;13(1):1182. doi: 10.1038/s41467-022-28738-2. Nat Commun. 2022. PMID: 35256603 Free PMC article.

8

TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis.

Yu Z, Wen Y, Jiang N, Li Z, Guan J, Zhang Y, Deng C, Zhao L, Zheng SG, Zhu Y, Su W, Zhuo Y. Yu Z, et al. Among authors: su w. Biomaterials. 2022 May;284:121484. doi: 10.1016/j.biomaterials.2022.121484. Epub 2022 Mar 25. Biomaterials. 2022. PMID: 35378413 Free article.

9

Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis.

Wang Z, Xia Q, Su W, Cao M, Sun Y, Zhang M, Chen W, Jiang T. Wang Z, et al. Among authors: su w. Front Cardiovasc Med. 2022 Feb 24;9:824756. doi: 10.3389/fcvm.2022.824756. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35282347 Free PMC article.

10

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.

Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, Totolyan N, Pingili R, Mancione L, Hu X, Sullivan R, Su W, Zielman R, Gupta AD, Montalban X, Winthrop K. Cross AH, et al. Among authors: su w. Neurol Ther. 2022 Jun;11(2):741-758. doi: 10.1007/s40120-022-00341-z. Epub 2022 Mar 13. Neurol Ther. 2022. PMID: 35284994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results